Innovation Pharmaceuticals Inc (IPIX)

[LilyGDog]

You are right on, the possibilities are pretty wide ranging. The human trials for COVID19 will help narrow Brilacidins effectiveness.

Go Leo & IPIX!

I don’t think so. B will more than likely be the drug to give for multiple other viruses: MRSA, SARS, all strains of pneumonia maybe, equine encephalitis, West Nile, nasty ole Lyme disease which wreaks havoc in New England, Zica virus, herpes, HIV, the flu (if so then maybe they are the paranoid BP’s and their powerful connections are behind any road blocks placed in IPIX’s path), hepatitis, shingles, the flesh-eating Staph A. virus, Dengue, Ebola, norovirus, rotavirus, meningitis bacterial as well as viral, mononucleosis, and many more. There had even been suggestions ( and this one is a stretch but who knows) that multiple sclerosis could possibly have a viral connection as people have the disease without any known family history of it...that people get MS as a virus and then it gets triggered/activates years later. Brilacidin has a place in therapeutics and from what I have read very inexpensive compared to other drugs already available to treat some of the above conditions but at a much higher cost so those biopharmas do not wish B to be successful, but, thanks to CV-19, and it’s unfortunate with all the loss of loved ones, has created a spark to ignite B’s success.